NCT05713448

Brief Summary

A registry of individuals with type 1 diabetes that visited the Department of Endocrinology of the University Hospitals of Leuven is established. The objective of this registry is to phenotype patients with type 1 diabetes and obesity and their response to treatment with regard to their outcomes

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100,000

participants targeted

Target at P75+ for all trials

Timeline
896mo left

Started Feb 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Feb 2021Dec 2099

Study Start

First participant enrolled

February 24, 2021

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

October 12, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 6, 2023

Completed
76.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2099

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2099

Last Updated

July 1, 2024

Status Verified

June 1, 2024

Enrollment Period

78.9 years

First QC Date

October 12, 2022

Last Update Submit

June 28, 2024

Conditions

Type 1 DiabetesObesity

Outcome Measures

Primary Outcomes (1)

  • Prevalence of patients with type 1 diabetes and obesity

    Prevalence of obesity in type 1 diabetes

    Up to 100 years

Study Arms (1)

Type 1 diabetes

Individuals with type 1 diabetes

Other: No intervention

Interventions

No interventionOTHER

No intervention

Type 1 diabetes

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Individuals with type 1 diabetes

You may qualify if:

  • Signed informed consent
  • Type 1 Diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Departement Endocrinology, University Hospitals Leuven

Leuven, 3000, Belgium

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Obesity

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Bart Van der Schueren, MD, PhD

CONTACT

+3216346994bart.vanderschueren@uzleuven.be

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
100 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2022

First Posted

February 6, 2023

Study Start

February 24, 2021

Primary Completion (Estimated)

December 29, 2099

Study Completion (Estimated)

December 29, 2099

Last Updated

July 1, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations

BE(1)